Technology ❯ Biotechnology

Drug Delivery Systems

Nanotechnology Lipid Nanoparticles Oral Medications Lipid-Based Delivery Implant Technology Implantable Drug Devices Lapscovery Technology mRNA Therapeutics Injectable Drug Delivery Nanoparticle-based Delivery Targeted Therapy Controlled Release Lipid Nanoparticle Technology Blood-Brain Barrier Kynatrix Technology Protein Delivery Oral Drug Technology Vaccine Delivery Technologies Oral Insulin Antibody-Drug Conjugates

Lilly Secures Global Rights to Hanmi’s Sonefpeglutide

The agreement gives Lilly exclusive development and commercial control outside Korea, with Hanmi taking a $75 million up‑front payment and large milestone and royalty upside.

Regeneron Strikes Parabilis Deal to Develop Antibody-Helicon Drugs

Lifeward Completes Oratech Deal and Maps Back‑Half 2026 Recovery After Q1 Setbacks

Moderna Reaches Up to $2.25 Billion LNP Patent Settlement, Pays $950 Million Upfront

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

Phenol-Modified Lipids Improve mRNA Therapeutics by Cutting Inflammation